Global Market for Cognitive Function and Memory Enhancement Agents (up to 2027): By Drug Type, Application, and Region
360iResearch predicts that the global cognitive function and memory enhancement market, which was valued at $4,963.34 million in 2021, will reach $5,424.52 million in 2022 and expand to $8,541.11 million by 2027, growing at a CAGR of 9.46%. This research report provides a multifaceted analysis of the global market for cognitive function and memory enhancement, including sections on introduction, research methodology, executive summary, market overview, market insights, analysis by drug type (Adderall, Aricept, Exelon, Namenda, Provigil), analysis by application (intellectual learning ability, physical ability, disease treatment), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.